Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/13/2010CN101085077B 'Capsule for treating psoriasis
10/13/2010CN101019869B Medicine composition of alprostadil and Chuanhuning/Yanhuning liposome and its preparation
10/13/2010CN101007115B 'Qihong' oral liquid
10/13/2010CN101007014B A compound puerarin preparation
10/12/2010US7812152 Amphiphilic cyclodextrin derivatives, method for preparation thereof and uses thereof
10/12/2010US7812120 Nasal calcitonin formulations containing chlorobutanol
10/12/2010US7812010 Pharmaceutical preparations for treatments of diseases and disorders of the breast
10/12/2010US7812009 Mastitis treatment
10/12/2010US7811991 Polypeptide therapeutic for treating ischemia associated with perioperative surgical procedure
10/12/2010US7811988 A lipid mixture for synthetic surfactants comprising >40% by weight of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and >10% of polyunsaturated phospholipids; treatment of surfactant deficiencies like infant respiratory distress syndrome (RDS); rheology; low surface tension; fast spreading
10/12/2010US7811797 producing cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods
10/12/2010US7811606 Beclomethasone powders has specific particle size distribution; increase bioavailability, prolonged therapeutic effect of the drug substance; aqueous suspension for inhalation; drug delivery method and device; rhinitis treatment
10/12/2010US7811605 If the hydrogel particles are sufficiently small, substances dispersed in them will diffuse to the surface and be released at essentially the same rate
10/12/2010US7811604 disintegrant such as crospovidone, croscarmellose sodium, sodium starch glycolate; free of acids, water-soluble polymers, taste-masking polymers, and coatings; formed by dry compression; for treatment of schizophrenia
10/12/2010US7811603 complex formed between cationic lipid (comprises N-[1-(2,3-dioleyloxy) propyl]-N,N,N-trimetylammonium chloride/1,2-Dioleoyl-sn-glycero-phosphatidylethanolamine) and nucleic acid (DNA); improved gene transfection, gene therapy
10/12/2010US7811602 contains phospholipid and cholesterol, MnSO4 or MgSO4 within, and anticancer agent such as vinca alkaloids; increased retention; leukemia, lymphoma
10/12/2010US7811601 Naphazoline nitrate; hydrophilic; copolymer of hydroxyalkyl acrylate, alkylphosphate ester of methacrylic acid, methacrylamide; ionic gel
10/12/2010US7811597 thermoplastic elastomer such as ethylene/propylene rubber, very low density polyethylene, eucalyptus oil odorant, salicylic acid ester, menthol and camphor; repels animals such as cats, dogs, rats, and crows; cable insulation
10/12/2010US7811593 Pharmaceutical composition with combined active agents and methods for using the same
10/12/2010US7811488 Method for manufacturing molded article with core
10/12/2010US7811279 Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
10/12/2010US7810643 package backing with columns and rows to hold tablets marked for days and weeks; glaucoma
10/12/2010CA2620738C Tablet for removing tongue coating
10/12/2010CA2543743C Bovine germicide application device
10/12/2010CA2534285C Coated water-swellable material
10/12/2010CA2521559C Fluidization of particles for encapsulation in oral dosage pharmaceutical products
10/12/2010CA2491295C Compressed chewing gum
10/12/2010CA2456356C Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
10/12/2010CA2449502C Homogenate for implants and microparticles
10/12/2010CA2439097C Pharmaceutical compositions
10/12/2010CA2438657C Testosterone-containing transdermal therapeutic system and process for its production
10/12/2010CA2425420C Administration of resveratrol to treat inflammatory respiratory disorders
10/12/2010CA2413699C Topical pharmaceutical formulations and methods of treatment
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2376305C Sulfonamide and sulfamide substituted imidazoquinolines
10/12/2010CA2375599C Probiotic compositions comprising e. coli and volatile fractions of plant extracts
10/12/2010CA2374933C Grf-containing lyophilized pharmaceutical compositions
10/12/2010CA2336542C Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them
10/10/2010CA2699180A1 Patch and patch preparation
10/09/2010CA2697576A1 Granulate for the formulation of orodispersible tablets
10/07/2010WO2010115172A2 Antigenic peptide of hsv-2 and methods for using same
10/07/2010WO2010115032A1 Pulmonary and nasal delivery of serum amyloid p
10/07/2010WO2010115015A1 Modified-release pharmaceutical drug composition
10/07/2010WO2010115013A2 Functionalized fullerenes as antifungal agents
10/07/2010WO2010114982A2 Lyophilization cakes of proteasome inhibitors
10/07/2010WO2010114901A1 Method of controlled drug release from a liposome carrier
10/07/2010WO2010114828A1 Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
10/07/2010WO2010114827A1 Regulation of bone growth using zeolite in combination with bone graft substitutes
10/07/2010WO2010114816A1 Nicotine dissolving film with or without menthol
10/07/2010WO2010114797A1 Protein-assisted drug delivery system for the targeted administration of active agents for overcoming blood-brain barrier
10/07/2010WO2010114768A1 Polymer-epothilone conjugates, particles, compositions, and related methods of use
10/07/2010WO2010114710A2 An artificial micro-gland
10/07/2010WO2010114629A2 Formulation
10/07/2010WO2010114622A1 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
10/07/2010WO2010114601A1 Multiamino acid-based poly (ester amide)s
10/07/2010WO2010114405A2 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
10/07/2010WO2010114404A1 Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
10/07/2010WO2010114134A1 Hard capsule
10/07/2010WO2010114121A1 Aqueous gel base and aqueous gel plaster
10/07/2010WO2010113984A1 Liposome composition
10/07/2010WO2010113983A1 Method for producing liposome composition
10/07/2010WO2010113900A1 Production method for ubiquinone powder for use in preparations and product thereof
10/07/2010WO2010113841A1 Orally disintegrating coated tablet
10/07/2010WO2010113840A1 Solid pharmaceutical composition containing amorphous body of solifenacin
10/07/2010WO2010113688A1 Composition for oral cavity
10/07/2010WO2010113325A1 Pectin-containing jelly preparation
10/07/2010WO2010113324A1 Pectin-containing jelly preparation
10/07/2010WO2010113225A1 Riluzole-containing transdermal patch
10/07/2010WO2010112965A1 Isolation coating of diclofenac tablets
10/07/2010WO2010112829A1 Intimate lubrication kit
10/07/2010WO2010112762A1 Functionalized pharmaceutical carrier improving the bioavailability of active substances having a very low solubility, and microgranules containing same
10/07/2010WO2010112760A1 Method for extracting non-volatile compounds
10/07/2010WO2010112749A1 Solid lipid nanoparticles encapsulating minoxidil, and aqueous suspension containing same
10/07/2010WO2010112702A1 Method for preparing pharmaceutical compositions comprising fine particles of active substance
10/07/2010WO2010112578A1 4 -isopropyl-3-methylphenol for the treatment of inflammation
10/07/2010WO2010112577A1 Antibacterial composition comprising 4 -isopropyl-3-methylpheno and zinc ions
10/07/2010WO2010112541A1 Pharmaceutical composition containing a limus family immunosuppressive macrolide
10/07/2010WO2010112489A2 Method for producing preparations of substances poorly soluble in water
10/07/2010WO2010112244A1 Applicator for treating skin
10/07/2010WO2010112222A1 Progressive emulsion crystallization
10/07/2010WO2010112221A1 Pharmaceutical compositions comprising memantine
10/07/2010WO2010112203A1 Pills comprising dapoxetin and dry processing methods for the production thereof
10/07/2010WO2010111912A1 Method of preparing nano-dispersed high-all-trans-carotenoid microcapsules
10/07/2010WO2010111905A1 Pharmaceutical composition for treatment of 2 type dabetes
10/07/2010WO2010111886A1 Traditional chinese medicinal ointment for treating burn, scald and infective trauma and preparative method thereof
10/07/2010WO2010111807A1 A polysaccharide liposome, the preparation method and use of it
10/07/2010WO2010111759A1 Stabiliser-free pharmaceutical compositions of tetrahydrolipstatin
10/07/2010WO2010084111A3 Pharmaceutical composition of ibandronate sodium salt or a hydrate thereof
10/07/2010WO2010082220A3 Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
10/07/2010WO2010080754A3 Nanoparticle pharmaceutical formulations
10/07/2010WO2010071313A3 Granules containing lacidipine, and pharmaceutical compositions comprising same
10/07/2010WO2010069795A3 Capecitabine rapidly disintegrating tablets
10/07/2010WO2010065660A3 Biodegradable polydisulfide amines for gene delivery
10/07/2010WO2010058104A3 Pharmaceutical compositions containing inulin as granulation carrier
10/07/2010WO2010052430A3 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine
10/07/2010WO2010048623A9 Medical and imaging nanoclusters
10/07/2010WO2010048389A3 Vaginal pellets comprising debranched starch
10/07/2010WO2010034901A3 Gel adapted for transmitting ultrasound waves, method for making said gel, and bag containing same
10/07/2010WO2010015665A3 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
10/07/2010WO2009149150A3 Composition comprising liposome-entrapped doxorubicin and methods of administration
1 ... 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 ... 2991